NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate how well MER511 is tolerated and what side effects may occur in adults who have Graves\' disease. The study drug will be administered either intravenously (into a vein in the arm) or subcutaneously (under the skin). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Epistemonikos ID: 2d951157ef22a270d7a2a8cf0874990282bade1b
First added on: Dec 27, 2025